バイオメディカルテキスタイル市場：ファイバーマネージャー、生地タイプ、用途別-2025-2030年世界予測

バイオメディカルテキスタイル市場の2023年の市場規模は126億1,000万米ドルで、2024年には135億4,000万米ドルに達すると予測され、CAGR 7.48％で成長し、2030年には209億1,000万米ドルに達すると予測されています。

バイオメディカルテキスタイルは、生体システムと相互作用する医療用に設計された特殊な織物であり、創傷被覆材から移植可能な装置まで幅広い範囲を網羅しています。これらのテキスタイルは、その生体適合性、滅菌性、機能的多様性からヘルスケアにおいて極めて重要であり、手術用縫合糸から人工皮膚までの用途に対応しています。革新的なバイオメディカルテキスタイルの必要性は、慢性疾患の増加、人口の高齢化、外科手術の増加によって推進され、抗菌加工や生物活性テキスタイルなどの素材の進歩を促進しています。最終用途は病院、診療所、在宅ケアに及び、個別化医療ソリューションが重視されるようになっています。市場を形成する主な成長要因には、技術の進歩、研究開発投資の増加、世界のヘルスケア支出の増加などがあります。さらに、COVID-19の大流行により感染予防を目的とした技術革新が加速し、抗菌・抗ウイルス繊維製品の潜在的なビジネスチャンスが拡大しています。とはいえ、厳しい規制遵守、高い生産コスト、市場の成長を妨げる可能性のある材料の制限などの課題も残っています。新たなビジネスチャンスの活用を目指す企業にとっては、健康パラメーターをモニターするスマートテキスタイルや有機生分解性繊維などのイノベーションに注力することで、競争力を高めることができます。テキスタイルとIoTの交差点は未開拓のイノベーションの道を提示しており、ウェアラブル健康モニタリング・デバイスには大きな成長の余地があります。バイオテキスタイルを管理する厳しい国際基準への適応と持続可能な生産技術への投資は、市場の拡大に好影響を与えそうです。市場競争は激しいが、戦略的パートナーシップやコラボレーションは開発努力を促進し、新規参入企業の参入障壁の高さなどの課題を克服するのに役立ちます。全体として、バイオメディカルテキスタイル市場は、緊急の臨床ニーズと技術的相乗効果に牽引され、スマートで持続可能な製品ラインにおける差別化の機会とともに、力強い成長の可能性を示しています。

市場力学：急速に進化するバイオメディカルテキスタイル市場の主要市場インサイトを公開

バイオメディカルテキスタイル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 事故・手術件数の増加
  • 高齢化人口の急増とヘルスケア支出の増加
  • 摩耗を防ぎ、組織の成長を促すTAVR用織物の需要
• 市場抑制要因
  • 複雑な原材料と多額の投資
• 市場機会
  • 外科手術用ロボットの進歩により、テキスタイル開発者と医療機器OEMの緊密な連携が必要
  • スマートなバイオメディカルテキスタイルの進歩
• 市場の課題
  • 学際的な知識を持つ熟練した人材の不足

ポーターの5つの力：バイオメディカルテキスタイル市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオメディカルテキスタイル市場における外部からの影響の把握

外部マクロ環境要因は、バイオメディカルテキスタイル市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオメディカルテキスタイル市場における競合情勢の把握

バイオメディカルテキスタイル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオメディカルテキスタイル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオメディカルテキスタイル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオメディカルテキスタイル市場における成功への道筋を描く

バイオメディカルテキスタイル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 事故や手術の増加
    • 高齢化の急速な増加とヘルスケア費の増加
    • 摩耗を防ぎ、組織の成長を促進するTAVRを組み込んだ繊維の需要
  • 抑制要因
    • 複雑な原材料と多額の投資
  • 機会
    • 外科用ロボットの進歩により、繊維開発者と医療機器OEMの緊密な連携が実現
    • スマートバイオメディカルテキスタイルの進歩
  • 課題
    • 学際的な知識を持つ熟練した人材の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオメディカルテキスタイル市場ファイバーマネージャー

• 生分解性繊維
  • キチン
  • コラーゲン
• 非生分解性繊維
  • コットン
  • ポリアミド
  • ポリエステル
  • ポリプロピレンとポリエチレン
  • ポリテトラフルオロエチレン
  • ポリウレタン
  • ビスコース

第7章 バイオメディカルテキスタイル市場生地の種類別

• 中空生地
• ニット生地と編み生地
• 不織布
• 織物

第8章 バイオメディカルテキスタイル市場：用途別

• 体外装置
• 埋め込み型
  • 歯科補綴
  • 硬組織インプラント
  • 軟部組織インプラント
  • 血管デバイス
• 非インプラント
• 外科用縫合糸

第9章 南北アメリカのバイオメディカルテキスタイル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のバイオメディカルテキスタイル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのバイオメディカルテキスタイル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• ARAN BIOMEDICAL
• Asahi Kasei Corporation
• ATEX Technologies, Inc.
• B. Braun Melsungen AG
• Bally Ribbon Mills
• BSN Medical by Svenska Cellulosa Aktiebolaget SCA
• Cardinal Health, Inc
• Confluent Medical Technologies
• CORTLAND BIOMEDICAL by Tufropes Pvt Ltd.
• Integra LifeSciences Corporation
• J-Pac, LLC
• Johnson & Johnson Services Inc.
• Koninklijke DSM N.V.
• Medline Industries, LP
• Medtronic PLC
• Meister & Cie AG
• PAUL HARTMANN AG
• Poly-Med Incorporated
• Schouw & Co AS
• Secant Group LLC
• Shieldex by Statex Production and Sales GmbH
• SurgicalMesh
• Swicofil AG
• The Freudenberg Group
• W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. BIOMEDICAL TEXTILE MARKET RESEARCH PROCESS
• FIGURE 2. BIOMEDICAL TEXTILE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BIOMEDICAL TEXTILE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BIOMEDICAL TEXTILE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BIOMEDICAL TEXTILE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BIOMEDICAL TEXTILE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BIOMEDICAL TEXTILE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BIOMEDICAL TEXTILE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BIOMEDICAL TEXTILE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BIOMEDICAL TEXTILE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOMEDICAL TEXTILE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOMEDICAL TEXTILE MARKET DYNAMICS
• TABLE 7. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY CHITIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY COTTON, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY POLYAMIDE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY POLYESTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY POLYPROPYLENE & POLYETHYLENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY VISCOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY HOLLOW FABRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY KNITTED & BRAIDED FABRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY NON-WOVEN FABRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY WOVEN FABRIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY EXTRACORPOREAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY DENTAL PROSTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY HARD TISSUE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY SOFT TISSUE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY VASCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY NON-IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL BIOMEDICAL TEXTILE MARKET SIZE, BY SURGICAL SUTURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS BIOMEDICAL TEXTILE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 55. CANADA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 56. CANADA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 57. CANADA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 58. CANADA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 59. CANADA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. CANADA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 63. MEXICO BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 70. UNITED STATES BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES BIOMEDICAL TEXTILE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 78. ASIA-PACIFIC BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC BIOMEDICAL TEXTILE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 83. AUSTRALIA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 84. AUSTRALIA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 85. AUSTRALIA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. AUSTRALIA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 87. CHINA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 88. CHINA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 89. CHINA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 90. CHINA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 91. CHINA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. CHINA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 93. INDIA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 94. INDIA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 95. INDIA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 96. INDIA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 97. INDIA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. INDIA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 101. INDONESIA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 102. INDONESIA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 103. INDONESIA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. INDONESIA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 107. JAPAN BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 108. JAPAN BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 109. JAPAN BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. JAPAN BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 113. MALAYSIA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 114. MALAYSIA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 115. MALAYSIA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. MALAYSIA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 119. PHILIPPINES BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 120. PHILIPPINES BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 121. PHILIPPINES BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. PHILIPPINES BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 125. SINGAPORE BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 126. SINGAPORE BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SINGAPORE BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SINGAPORE BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH KOREA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH KOREA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 137. TAIWAN BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 138. TAIWAN BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TAIWAN BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TAIWAN BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 143. THAILAND BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 144. THAILAND BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 145. THAILAND BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. THAILAND BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 149. VIETNAM BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 150. VIETNAM BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 151. VIETNAM BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. VIETNAM BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 162. DENMARK BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 163. DENMARK BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 164. DENMARK BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. DENMARK BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 168. EGYPT BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 169. EGYPT BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 170. EGYPT BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. EGYPT BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 174. FINLAND BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 175. FINLAND BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 176. FINLAND BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. FINLAND BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 180. FRANCE BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 181. FRANCE BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 182. FRANCE BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. FRANCE BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 186. GERMANY BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 187. GERMANY BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 188. GERMANY BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. GERMANY BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 192. ISRAEL BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 193. ISRAEL BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 194. ISRAEL BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. ISRAEL BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 196. ITALY BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 197. ITALY BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 198. ITALY BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 199. ITALY BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 200. ITALY BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. ITALY BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 204. NETHERLANDS BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 205. NETHERLANDS BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 206. NETHERLANDS BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. NETHERLANDS BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 210. NIGERIA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 211. NIGERIA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 212. NIGERIA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. NIGERIA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 216. NORWAY BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 217. NORWAY BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 218. NORWAY BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. NORWAY BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 220. POLAND BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 221. POLAND BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 222. POLAND BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 223. POLAND BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 224. POLAND BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. POLAND BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 226. QATAR BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 227. QATAR BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 228. QATAR BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 229. QATAR BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 230. QATAR BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. QATAR BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 234. RUSSIA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 235. RUSSIA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 236. RUSSIA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. RUSSIA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 240. SAUDI ARABIA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 242. SAUDI ARABIA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 252. SPAIN BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 253. SPAIN BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 254. SPAIN BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 255. SPAIN BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 258. SWEDEN BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 259. SWEDEN BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 260. SWEDEN BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 261. SWEDEN BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 264. SWITZERLAND BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 265. SWITZERLAND BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 266. SWITZERLAND BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 267. SWITZERLAND BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 270. TURKEY BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 271. TURKEY BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 272. TURKEY BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 273. TURKEY BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM BIOMEDICAL TEXTILE MARKET SIZE, BY FIBER MANAGER, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM BIOMEDICAL TEXTILE MARKET SIZE, BY BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 282. UNITED KINGDOM BIOMEDICAL TEXTILE MARKET SIZE, BY NON-BIODEGRADABLE FIBER, 2018-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM BIOMEDICAL TEXTILE MARKET SIZE, BY FABRIC TYPE, 2018-2030 (USD MILLION)
• TABLE 284. UNITED KINGDOM BIOMEDICAL TEXTILE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM BIOMEDICAL TEXTILE MARKET SIZE, BY IMPLANTABLE, 2018-2030 (USD MILLION)
• TABLE 286. BIOMEDICAL TEXTILE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 287. BIOMEDICAL TEXTILE MARKET, FPNV POSITIONING MATRIX, 2023

The Biomedical Textile Market was valued at USD 12.61 billion in 2023, expected to reach USD 13.54 billion in 2024, and is projected to grow at a CAGR of 7.48%, to USD 20.91 billion by 2030.

Biomedical textiles are specialized fabrics engineered for medical purposes that interact with biological systems, encompassing a wide scope from wound dressings to implantable devices. These textiles are crucial in healthcare for their biocompatibility, sterilizability, and functional versatility, addressing applications from surgical sutures to prosthetic skins. The necessity for innovative biomedical textiles is propelled by the increasing incidence of chronic diseases, aging populations, and heightened surgical interventions, fostering advancements in materials such as antimicrobial finishes and bioactive textiles. End-use applications span hospitals, clinics, and homecare, with a growing emphasis on personalized medicine solutions. Key growth factors shaping the market include technological advancements, increased R&D investment, and rising healthcare expenditure globally. Additionally, the COVID-19 pandemic has accelerated innovations aimed at infection prevention, expanding potential opportunities for antimicrobial and antiviral textiles. Nevertheless, challenges persist, such as stringent regulatory compliances, high production costs, and material limitations that may hinder market growth. For businesses aiming to capitalize on emerging opportunities, focusing on innovations such as smart textiles that monitor health parameters or organic, biodegradable fibers can offer competitive edges. The intersection of textiles with IoT presents unexplored avenues for innovation, with significant room for growth in wearable health monitoring devices. Adaptation to the stringent international standards governing bio-textiles and investment in sustainable production technologies will likely influence market expansion favorably. While the market is competitive, strategic partnerships and collaborations can advance development efforts, helping navigate challenges like high entry barriers for new entrants. Overall, the biomedical textile market presents robust growth potential driven by urgent clinical needs and technological synergy, with opportunities for differentiation in smart and sustainable product lines.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biomedical Textile Market

The Biomedical Textile Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of accidents and surgeries
  • Rapid growth in the aging population, and increased healthcare expenditure
  • Demand for TAVR incorporated textiles to prevent abrasion and encourage tissue growth
• Market Restraints
  • Complex raw material and heavy investments
• Market Opportunities
  • Advancements in surgical robotics resulting for close collaboration between textile developers and medical device OEMs
  • Advancements in smart biomedical textiles
• Market Challenges
  • Lack of trained skilled manpower with interdisciplinary knowledge

Porter's Five Forces: A Strategic Tool for Navigating the Biomedical Textile Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biomedical Textile Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biomedical Textile Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biomedical Textile Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biomedical Textile Market

A detailed market share analysis in the Biomedical Textile Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biomedical Textile Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biomedical Textile Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biomedical Textile Market

A strategic analysis of the Biomedical Textile Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biomedical Textile Market, highlighting leading vendors and their innovative profiles. These include ARAN BIOMEDICAL, Asahi Kasei Corporation, ATEX Technologies, Inc., B. Braun Melsungen AG, Bally Ribbon Mills, BSN Medical by Svenska Cellulosa Aktiebolaget SCA, Cardinal Health, Inc, Confluent Medical Technologies, CORTLAND BIOMEDICAL by Tufropes Pvt Ltd., Integra LifeSciences Corporation, J-Pac, LLC, Johnson & Johnson Services Inc., Koninklijke DSM N.V., Medline Industries, LP, Medtronic PLC, Meister & Cie AG, PAUL HARTMANN AG, Poly-Med Incorporated, Schouw & Co AS, Secant Group LLC, Shieldex by Statex Production and Sales GmbH, SurgicalMesh, Swicofil AG, The Freudenberg Group, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Biomedical Textile Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Fiber Manager, market is studied across Biodegradable Fiber and Non-Biodegradable Fiber. The Biodegradable Fiber is further studied across Chitin and Collagen. The Non-Biodegradable Fiber is further studied across Cotton, Polyamide, Polyester, Polypropylene & Polyethylene, Polytetrafluoroethylene, Polyurethane, and Viscose.
• Based on Fabric Type, market is studied across Hollow Fabric, Knitted & Braided Fabric, Non-Woven Fabric, and Woven Fabric.
• Based on Application, market is studied across Extracorporeal Devices, Implantable, Non-Implantable, and Surgical Sutures. The Implantable is further studied across Dental Prosthesis, Hard Tissue Implants, Soft Tissue Implants, and Vascular Devices.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of accidents and surgeries
    • 5.1.1.2. Rapid growth in the aging population, and increased healthcare expenditure
    • 5.1.1.3. Demand for TAVR incorporated textiles to prevent abrasion and encourage tissue growth
  • 5.1.2. Restraints
    • 5.1.2.1. Complex raw material and heavy investments
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in surgical robotics resulting for close collaboration between textile developers and medical device OEMs
    • 5.1.3.2. Advancements in smart biomedical textiles
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of trained skilled manpower with interdisciplinary knowledge
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biomedical Textile Market, by Fiber Manager

• 6.1. Introduction
• 6.2. Biodegradable Fiber
  • 6.2.1. Chitin
  • 6.2.2. Collagen
• 6.3. Non-Biodegradable Fiber
  • 6.3.1. Cotton
  • 6.3.2. Polyamide
  • 6.3.3. Polyester
  • 6.3.4. Polypropylene & Polyethylene
  • 6.3.5. Polytetrafluoroethylene
  • 6.3.6. Polyurethane
  • 6.3.7. Viscose

7. Biomedical Textile Market, by Fabric Type

• 7.1. Introduction
• 7.2. Hollow Fabric
• 7.3. Knitted & Braided Fabric
• 7.4. Non-Woven Fabric
• 7.5. Woven Fabric

8. Biomedical Textile Market, by Application

• 8.1. Introduction
• 8.2. Extracorporeal Devices
• 8.3. Implantable
  • 8.3.1. Dental Prosthesis
  • 8.3.2. Hard Tissue Implants
  • 8.3.3. Soft Tissue Implants
  • 8.3.4. Vascular Devices
• 8.4. Non-Implantable
• 8.5. Surgical Sutures

9. Americas Biomedical Textile Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Biomedical Textile Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Biomedical Textile Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. ARAN BIOMEDICAL
• 2. Asahi Kasei Corporation
• 3. ATEX Technologies, Inc.
• 4. B. Braun Melsungen AG
• 5. Bally Ribbon Mills
• 6. BSN Medical by Svenska Cellulosa Aktiebolaget SCA
• 7. Cardinal Health, Inc
• 8. Confluent Medical Technologies
• 9. CORTLAND BIOMEDICAL by Tufropes Pvt Ltd.
• 10. Integra LifeSciences Corporation
• 11. J-Pac, LLC
• 12. Johnson & Johnson Services Inc.
• 13. Koninklijke DSM N.V.
• 14. Medline Industries, LP
• 15. Medtronic PLC
• 16. Meister & Cie AG
• 17. PAUL HARTMANN AG
• 18. Poly-Med Incorporated
• 19. Schouw & Co AS
• 20. Secant Group LLC
• 21. Shieldex by Statex Production and Sales GmbH
• 22. SurgicalMesh
• 23. Swicofil AG
• 24. The Freudenberg Group
• 25. W. L. Gore & Associates, Inc.